日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語(yǔ)Fran?ais
Lifestyle
Home / Lifestyle / Health

Transparency needed for oversight of vaccine-makers

By Wang Xiaoyu | China Daily | Updated: 2018-11-22 10:25
Share
Share - WeChat

Experts called for more transparency in vaccine supervision after China's drug regulator disclosed on Tuesday that it had denied market access for more than 100,000 doses of rabies vaccine produced by two manufacturers in Jilin province.

Some 43,510 doses from Maifeng Bio Tech Co failed premarket checks of safety and effectiveness on Oct 29, as did 57,290 doses from Zhuoyi Biological Co on Nov 5. Both manufacturers are based in Changchun, Jilin.

The checks were conducted by the National Institutes for Food and Drug Control, which released the information about the substandard vaccines on its website.

Also in October, the authority denied market access to 77,516 doses of a rabies vaccine made by Chengda Biotech in Shenyang, Liaoning province.

Wang Yuedan, a professor at Peking University Health Science Center's immunology school, said rising public concern about vaccine quality prompted the regulator to release more information on substandard products.

"The latest disclosure of market denial is not directly linked to stricter vaccine management. It's more of an answer to public demand for more information on the production and supervision of rabies vaccines," he said.

Zeng Guang, an epidemiologist at China's Center for Disease Control and Prevention, said it's crucial to promote dialogue between the drug regulator, vaccine manufacturers and the public.

"Manufacturers should be notified of their products' problems to improve production," he said. "And the public is also entitled to be aware of quality issues."

While the notice didn't say why market access was denied, Wang said, the reasons are most likely associated with low effectiveness or excessive levels of contaminants in the drugs.

"China is a huge market for rabies vaccines, and many manufacturers tap into the market," he said. "Not all producers hold themselves to high standards."

China has been rolling out new measures to tighten its supervision of vaccine-makers following a major quality scandal that involved Changchun Changsheng Bio-tech Co, a large producer found to have made substandard vaccines.

The National Medical Products Administration pledged early this month to prioritize building an online tracking system for vaccines, anesthetics and psychoactive drugs to ensure their safety.

On Nov 12, a draft vaccine law was released by the State Administration for Market Regulation for public feedback. If approved, companies that make illegal or substandard vaccines could face fines of up to 10 times the value of the products.

?

Most Popular
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 偷拍—91porny九色 | 国产成人91 | 亚洲成人免费视频在线观看 | 国产一有一级毛片视频 | 粉嫩粉嫩芽的虎白女18在线视频 | 欧美双插| 国产在线视频网 | 色老头综合网 | 国产精品一区视频 | 国产苐1页影院草草影院 | 污污的网站在线观看 | 久久久久国产一区二区三区 | 99热这里有免费国产精品 | 免费自拍偷拍 | 夜夜操天天操 | 亚洲国产日韩在线观看 | 91茄子国产线观看免费 | 国产日韩一区二区三区在线观看 | 91短视频版在线观看免费大全 | wwwwxxxx免费 | 日韩欧美在线免费观看 | 亚洲狠狠婷婷综合久久蜜桃 | 国产欧美一区二区精品忘忧草 | 一级做a | 欧美日韩一区精品 | 日本免费不卡在线一区二区三区 | 一区二区视频在线 | 国产精品久久久久久久一区探花 | 色噜噜亚洲男人的天堂 | 国产综合在线播放 | 国产精品点击进入在线影院高清 | 精品久久久久久久久久久 | 亚州综合 | 亚洲国产精品一区二区第一页 | 黄色一级视频网站 | 成人a网 | 激情 一区 | 日本高清天码一区在线播放 | 99热久久这里只有精品首页 | 中文字幕国产精品 | 九九视频精品全部免费播放 |